2023-06-01 2024-05-31 false Capium Accounts Production 1.1 11361325 2023-06-01 2024-05-31 11361325 bus:AbridgedAccounts 2023-06-01 2024-05-31 11361325 bus:FRS102 2023-06-01 2024-05-31 11361325 bus:AuditExempt-NoAccountantsReport 2023-06-01 2024-05-31 11361325 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 11361325 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 11361325 2023-06-01 2024-05-31 11361325 2024-05-31 11361325 bus:RegisteredOffice 2023-06-01 2024-05-31 11361325 core:WithinOneYear 2024-05-31 11361325 core:AfterOneYear 2024-05-31 11361325 1 2023-06-01 2024-05-31 11361325 bus:Director1 2023-06-01 2024-05-31 11361325 bus:Director1 2024-05-31 11361325 bus:Director1 2022-06-01 2023-05-31 11361325 2022-06-01 11361325 bus:LeadAgentIfApplicable 2023-06-01 2024-05-31 11361325 2022-06-01 2023-05-31 11361325 2023-05-31 11361325 core:WithinOneYear 2023-05-31 11361325 core:AfterOneYear 2023-05-31 11361325 bus:EntityAccountantsOrAuditors 2022-06-01 2023-05-31 11361325 bus:OrdinaryShareClass1 2023-06-01 2024-05-31 11361325 bus:OrdinaryShareClass1 2024-05-31 11361325 bus:OrdinaryShareClass1 2022-06-01 2023-05-31 11361325 bus:OrdinaryShareClass1 2023-05-31 11361325 core:LandBuildings 2023-06-01 2024-05-31 11361325 core:LandBuildings 2024-05-31 11361325 core:LandBuildings 2023-05-31 11361325 core:ComputerEquipment 2023-06-01 2024-05-31 11361325 core:ComputerEquipment 2024-05-31 11361325 core:ComputerEquipment 2023-05-31 11361325 core:MotorCars 2023-06-01 2024-05-31 11361325 core:MotorCars 2024-05-31 11361325 core:MotorCars 2023-05-31 11361325 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-05-31 11361325 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-05-31 11361325 core:CostValuation core:Non-currentFinancialInstruments 2024-05-31 11361325 core:CostValuation core:Non-currentFinancialInstruments 2023-05-31 11361325 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-05-31 11361325 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-05-31 11361325 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-05-31 11361325 core:Non-currentFinancialInstruments 2024-05-31 11361325 core:Non-currentFinancialInstruments 2023-05-31 11361325 core:ShareCapital 2024-05-31 11361325 core:ShareCapital 2023-05-31 11361325 core:RetainedEarningsAccumulatedLosses 2024-05-31 11361325 core:RetainedEarningsAccumulatedLosses 2023-05-31 11361325 dpl:Item1 2023-06-01 11361325 dpl:Item1 2024-05-31 11361325 dpl:Item1 2022-06-01 11361325 dpl:Item1 2023-05-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11361325
England and Wales

 

 

 

BDS MEDICS LTD


Abridged Accounts
 


Period of accounts

Start date: 01 June 2023

End date: 31 May 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 1,033,040    990,702 
1,033,040    990,702 
Current assets      
Debtors 44,040   
Cash at bank and in hand 123,098    106,522 
167,138    106,522 
Creditors: amount falling due within one year (50,264)   (96,291)
Net current assets 116,874    10,231 
 
Total assets less current liabilities 1,149,914    1,000,933 
Creditors: amount falling due after more than one year (559,793)   (549,007)
Net assets 590,121    451,926 
 

Capital and reserves
     
Called up share capital 4 100    100 
Profit and loss account 590,021    451,826 
Shareholders' funds 590,121    451,926 
 


For the year ended 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 11 January 2025 and were signed by:


-------------------------------
Beata Mirza
Director
1
General Information
BDS MEDICS LTD is a private company, limited by shares, registered in England and Wales, registration number 11361325, registration address 5 St. Augustines Road, Doncaster, South Yorkshire , DN4 5LL.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of services supplied by the company.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Motor Vehicles 20% Reducing Balance
Computer Equipment 25% Reducing Balance
Investment properties
Investment properties are properties held to earn rentals and/or for capital appreciation.
Investment properties should be recognised initially at cost and subsequently investment properties are measured at fair value. Gains and losses arising from changes in the fair value of investment properties are included in profit or loss in the period in which they arise.
2.

Average number of employees


Average number of employees during the year was 1 (2023 : 1).
3.

Tangible fixed assets

Cost or valuation Land and Buildings   Computer Equipment   Motor Vehicles   Total
  £   £   £   £
At 01 June 2023 979,041    18,005      997,046 
Additions   2,641    54,090    56,731 
Disposals      
At 31 May 2024 979,041    20,646    54,090    1,053,777 
Depreciation
At 01 June 2023   6,344      6,344 
Charge for year   3,575    10,818    14,393 
On disposals      
At 31 May 2024   9,919    10,818    20,737 
Net book values
Closing balance as at 31 May 2024 979,041    10,727    43,272    1,033,040 
Opening balance as at 01 June 2023 979,041    11,661      990,702 

The net book value of Motor Vehicles includes £ 43,272 in respect of assets leased under finance leases or hire purchase contracts.

4.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
100 Class A shares of £1.00 each 100    100 
100    100 

2